| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
960 |
| issn |
1948-5875 |
| issueIdentifier |
9 |
| pageRange |
958-960 |
| publicationName |
ACS Medicinal Chemistry Letters |
| startingPage |
958 |
| bibliographicCitation |
Abdel-Magid AF. Indoleamine 2,3-dioxygenase inhibitors: potential treatment for cancer, sepsis, and more. ACS Med Chem Lett. 2014 Sep 11;5(9):958–60. PMID: 25264478; PMCID: PMC4173634. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2536b061f4fa620b7f2922179c1028f6 |
| date |
2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC4173634
https://pubmed.ncbi.nlm.nih.gov/25264478
https://doi.org/10.1021/ml5002773 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1948-5875
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Indoleamine 2,3-Dioxygenase Inhibitors: Potential Treatment for Cancer, Sepsis, and More |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10308
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.13.11.52 |